130 related articles for article (PubMed ID: 38064488)
1. Pharmacological Characterization of the Endocannabinoid Sensor GRAB
Singh S; Sarroza D; English A; McGrory M; Dong A; Zweifel L; Land BB; Li Y; Bruchas MR; Stella N
Cannabis Cannabinoid Res; 2023 Dec; ():. PubMed ID: 38064488
[No Abstract] [Full Text] [Related]
2. Pharmacological characterization of the endocannabinoid sensor GRAB
Singh S; Sarroza D; English A; McGrory M; Dong A; Zweifel L; Land BB; Li Y; Bruchas MR; Stella N
bioRxiv; 2023 Mar; ():. PubMed ID: 36945533
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological Evaluation of Cannabinoid Receptor Modulators Using GRAB
Shivshankar S; Nimely J; Puhl H; Iyer MR
Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732230
[TBL] [Abstract][Full Text] [Related]
4. A fluorescent sensor for spatiotemporally resolved imaging of endocannabinoid dynamics in vivo.
Dong A; He K; Dudok B; Farrell JS; Guan W; Liput DJ; Puhl HL; Cai R; Wang H; Duan J; Albarran E; Ding J; Lovinger DM; Li B; Soltesz I; Li Y
Nat Biotechnol; 2022 May; 40(5):787-798. PubMed ID: 34764491
[TBL] [Abstract][Full Text] [Related]
5.
Cherry AL; Wheeler MJ; Mathisova K; Di Miceli M
Front Neuroinform; 2024; 18():1294939. PubMed ID: 38404644
[TBL] [Abstract][Full Text] [Related]
6. Cell-autonomous and differential endocannabinoid signaling impacts the development of presynaptic retinal ganglion cell axon connectivity
Del Rio R; Serrano RG; Gomez E; Martinez JC; Edward MA; Santos RA; Diaz KS; Cohen-Cory S
Front Synaptic Neurosci; 2023; 15():1176864. PubMed ID: 37252636
[TBL] [Abstract][Full Text] [Related]
7. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons.
Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM
J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227
[TBL] [Abstract][Full Text] [Related]
8. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
9. Cannabidiol skews biased agonism at cannabinoid CB
Navarro G; Reyes-Resina I; Rivas-Santisteban R; Sánchez de Medina V; Morales P; Casano S; Ferreiro-Vera C; Lillo A; Aguinaga D; Jagerovic N; Nadal X; Franco R
Biochem Pharmacol; 2018 Nov; 157():148-158. PubMed ID: 30194918
[TBL] [Abstract][Full Text] [Related]
10. 2-Linoleoylglycerol Is a Partial Agonist of the Human Cannabinoid Type 1 Receptor that Can Suppress 2-Arachidonolyglycerol and Anandamide Activity.
Lu L; Williams G; Doherty P
Cannabis Cannabinoid Res; 2019; 4(4):231-239. PubMed ID: 31872059
[No Abstract] [Full Text] [Related]
11. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
Aly E; Masocha W
IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
[TBL] [Abstract][Full Text] [Related]
12. Terpenoids Commonly Found in
Heblinski M; Santiago M; Fletcher C; Stuart J; Connor M; McGregor IS; Arnold JC
Cannabis Cannabinoid Res; 2020; 5(4):305-317. PubMed ID: 33376801
[No Abstract] [Full Text] [Related]
13. Allosteric Modulators of the CB
Morales P; Goya P; Jagerovic N; Hernandez-Folgado L
Cannabis Cannabinoid Res; 2016; 1(1):22-30. PubMed ID: 28861476
[TBL] [Abstract][Full Text] [Related]
14. Positive allosteric modulation of type 1 cannabinoid receptors reduces spike-and-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg.
Roebuck AJ; Greba Q; Smolyakova AM; Alaverdashvili M; Marks WN; Garai S; Baglot SL; Petrie G; Cain SM; Snutch TP; Thakur GA; Hill MN; Howland JG; Laprairie RB
Neuropharmacology; 2021 Jun; 190():108553. PubMed ID: 33845076
[TBL] [Abstract][Full Text] [Related]
15. Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol-A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling.
Jakowiecki J; Abel R; Orzeł U; Pasznik P; Preissner R; Filipek S
Molecules; 2021 Apr; 26(9):. PubMed ID: 33922473
[TBL] [Abstract][Full Text] [Related]
16. Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase.
Navia-Paldanius D; Aaltonen N; Lehtonen M; Savinainen JR; Taschler U; Radner FP; Zimmermann R; Laitinen JT
Eur J Pharm Sci; 2015 Sep; 77():180-8. PubMed ID: 26070239
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis.
Fonseca BM; Correia-da-Silva G; Teixeira NA
J Physiol Biochem; 2018 May; 74(2):261-272. PubMed ID: 29441458
[TBL] [Abstract][Full Text] [Related]
18. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Tham M; Yilmaz O; Alaverdashvili M; Kelly MEM; Denovan-Wright EM; Laprairie RB
Br J Pharmacol; 2019 May; 176(10):1455-1469. PubMed ID: 29981240
[TBL] [Abstract][Full Text] [Related]
19. Participation of endocannabinoids in rapid suppression of stress responses by glucocorticoids in neonates.
Buwembo A; Long H; Walker CD
Neuroscience; 2013 Sep; 249():154-61. PubMed ID: 23131711
[TBL] [Abstract][Full Text] [Related]
20. Endocannabinoid signaling in hypothalamic-pituitary-adrenocortical axis recovery following stress: effects of indirect agonists and comparison of male and female mice.
Roberts CJ; Stuhr KL; Hutz MJ; Raff H; Hillard CJ
Pharmacol Biochem Behav; 2014 Feb; 117():17-24. PubMed ID: 24316201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
